Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.In the six months or so since the Covid-19 pandemic broke out in Wuhan, China, the pharma industry and university researchers from across the world have thrown themselves head-first into developing vaccines.
As of 7 July, there are 139 pre-clinical candidates and 21 clinical vaccines in development against SARS-CoV-2, the virus which causes Covid-19, according to the World Health Organization (WHO).
Of the 21 Covid-19 vaccines in clinical trials, lead candidates include Chinese biotech Sinovac’s CoronaVac and the University of Oxford and AstraZeneca’s ChAdOx1-S – both of these are in Phase III development.